Benign Prostatic Hyperplasia News and Research

RSS

Prostatitis - one of the most common urologic diseases in the U.S

Estimates on the number of males in the United States who will experience prostatitis during their lifetimes range up to 50 percent.

21 Jan 2008

Urinary complications in men over 45

As many as one in four men admitted to hospital with acute urinary retention will die within a year, finds a study published on bmj.com.

13 Nov 2007

Coping with urinary incontinence

For older adults, increased urinary frequency is fairly common.

26 Sep 2007

Barr confirms UROXATRAL patent challenge

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its UROXATRAL (alfuzosin hydrochloride extended-release tablets), 10mg.

25 Sep 2007

Black men do not have more aggressive prostate cancer

A University of Minnesota study of prostate cancer tumors from Caucasian and African-American men has shown no evidence that the cancer is more aggressive in black men.

18 Sep 2007

Shrinkage of prostate led to overestimation of cancer risk in finasteride trial

Reanalysis of data from the first long-term randomized trial of a chemopreventive agent for prostate cancer shows that the excess prevalence of high-grade prostate cancer in the drug-treated group may be attributable to shrinkage of the prostate at the time of biopsy.

13 Sep 2007

Finasteride will cause little or no sexual dysfunction for most men who decide to take it

Men and their physicians need not hesitate to use a drug proven effective in preventing prostate cancer out of concern that it is likely to cause sexual dysfunction, say authors of a study conducted by the Southwest Oncology Group.

20 Jul 2007

Ranbaxy receives tentative FDA approval for Tamsulosin capsules

Ranbaxy Pharmaceuticals has announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Tamsulosin Hydrochloride Capsules, 0.4 mg.

23 Jun 2007

Botox for enlarged prostate

Injecting botulinum toxin A, or Botox, into the prostate gland of men with enlarged prostate, eased symptoms and improved quality of life up to a year after the procedure, according to a study by researchers at the Chang Gung University Medical College, Taiwan, and the University of Pittsburgh School of Medicine.

24 May 2007

Regular exercise associated with reduced risk of benign prostatic hyperplasia

Protection against heart disease, stroke, diabetes, obesity, hypertension, memory loss, colon cancer, fractures, and depression should be enough to get men exercising.

4 May 2007

Prostate cancer treatment decisions can be complicated

For many men with early-stage prostate cancer, sorting out the treatment options can be overwhelming.

20 Apr 2007

Placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms

All physicians involved in the treatment of PBS/IC understand that the placebo effect likely plays a major role in treatment, and is important when evaluating drug trials.

19 Apr 2007

Severe form of "enlarged prostate" discovered

Millions of middle-aged and older men experience the symptoms of an enlarged prostate multiple times during the day and night. What they may not know is that the disease known as BPH (benign prostatic hyperplasia), marked by urgency and frequent urination, is not one but at least a pair of disorders, and that one of the pair - tied to a newly identified gene - has far more serious implications.

5 Feb 2007

New gold standard of care for overactive bladder

A major clinical trial finds that a combination of two common medications -- tolterodine (Detrol LA) and tamsulosin (Flomax) -- works better than either drug alone for men struggling with lower urinary tract symptoms, including tough-to-treat overactive bladder (OAB).

14 Nov 2006

Mayo clinic finds NSAIDs may prevent or delay enlarged prostate

Mayo Clinic researchers have found that taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen may prevent or delay benign prostatic hyperplasia.

30 Aug 2006

Men with enlarged prostate can benefit from Botox injection

When researchers at the Chang Gung University Medical College, Taiwan and the University of Pittsburgh School of Medicine injected botulinum toxin A, or Botox, into the prostate gland of men with benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, they found that it eased symptoms and improved quality of life.

23 May 2006

Alfuzosin may improve double-J stent related symptoms

The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.

9 Mar 2006

Saw Palmetto not effective at relieving prostate problems

The herbal remedy saw palmetto is no more effective than a placebo at treating symptoms related to enlargement of the prostate gland, according to a new study in the New England Journal of Medicine.

13 Feb 2006

Laserscope issued new U.S. patent

Laserscope announced today that it has been issued an important U.S. patent from the United States Patent and Trademark Office (USPTO) relating to the use of its Photoselective Vaporization (PV) method and technology for therapeutic treatment of benign prostatic hyperplasia (BPH) and other tissues in the human body.

26 Jan 2006

Viagra effectively treats urinary tract symptoms associated with prostate enlargement

Viagra (sildenafil citrate), known for improving erectile dysfunction (ED), also effectively treats the prostate and lower urinary tract symptoms (LUTS) associated with prostate enlargement that often occur with ED, a Northwestern University study has found.

21 Nov 2005